$XBI $129 +2%
Want to access our searchable database of over 900 catalyst events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!
Covid Updates
$MRNA +10% Supply update. source
$RIGL +15% Ph 2 data in hospitalized covid-19 patients. source
Pipeline Updates
$BSGM -1% Completes enrollment in PURE EP 2.0 clinical trial. source
$AKUS -2% AK-OTOF receives FDA Orphan Drug and Rare Pediatric designations. source
$VTVT +34% TTP399 receives FDA Breakthrough Therapy designation for type 1 diabetes. source
$GERN +3% Initiation of ph 2 study of imetelstat for myelofibrosis. source
$AXLA +10% IND cleared for AXA1125 for NASH. source
$APLS +2% Ph 1b 24 mo data of pegcetacoplan in geographic atrophy. source
$FBIO -10% & $ATXI -24% FDA didn't provide approval decision yet. source
Finance Updates
$AGTC -1% Licensing agreement for gene therapy treatment. source
$CERE +4% Non-dilutive financing based on milestone and royalty payments. source